ASP Isotopes Inc. (NASDAQ:ASPI) Sees Significant Growth in Short Interest

ASP Isotopes Inc. (NASDAQ:ASPI) was the recipient of a significant growth in short interest in the month of December. As of December 31st, there was short interest totalling 6,770,000 shares, a growth of 13.8% from the December 15th total of 5,950,000 shares. Currently, 14.6% of the company’s shares are short sold. Based on an average daily trading volume, of 5,090,000 shares, the days-to-cover ratio is presently 1.3 days.

ASP Isotopes Stock Performance

ASP Isotopes stock opened at $5.66 on Friday. The stock’s 50-day moving average is $5.51 and its 200-day moving average is $4.08. The company has a market cap of $404.07 million, a price-to-earnings ratio of -9.28 and a beta of 3.48. The company has a debt-to-equity ratio of 0.80, a current ratio of 7.55 and a quick ratio of 7.54. ASP Isotopes has a 12 month low of $1.86 and a 12 month high of $9.33.

Analyst Upgrades and Downgrades

Several equities analysts recently weighed in on ASPI shares. Canaccord Genuity Group reiterated a “buy” rating and set a $4.50 target price on shares of ASP Isotopes in a research report on Friday, October 18th. Canaccord Genuity Group started coverage on ASP Isotopes in a research report on Friday, October 4th. They set a “buy” rating and a $4.50 target price on the stock.

Hedge Funds Weigh In On ASP Isotopes

A number of large investors have recently modified their holdings of the company. BNP PARIBAS ASSET MANAGEMENT Holding S.A. purchased a new position in shares of ASP Isotopes in the 3rd quarter worth about $6,249,000. Telemark Asset Management LLC acquired a new stake in shares of ASP Isotopes in the third quarter valued at about $4,726,000. Geode Capital Management LLC grew its stake in shares of ASP Isotopes by 42.7% in the third quarter. Geode Capital Management LLC now owns 1,118,423 shares of the company’s stock valued at $3,110,000 after buying an additional 334,836 shares in the last quarter. Philadelphia Financial Management of San Francisco LLC grew its stake in shares of ASP Isotopes by 158.3% in the third quarter. Philadelphia Financial Management of San Francisco LLC now owns 991,863 shares of the company’s stock valued at $2,757,000 after buying an additional 607,893 shares in the last quarter. Finally, State Street Corp grew its stake in shares of ASP Isotopes by 12.8% in the third quarter. State Street Corp now owns 853,695 shares of the company’s stock valued at $2,373,000 after buying an additional 96,604 shares in the last quarter. 16.80% of the stock is currently owned by hedge funds and other institutional investors.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.